Advertisement

Cytarabine/daunorubicin/midostaurin

Various toxicities: 4 case reports

    • 7 Accesses

    This is a preview of subscription content, log in to check access.

    Access options

    Buy single article

    Instant unlimited access to the full article PDF.

    US$ 49.95

    Price includes VAT for USA

    Reference

    1. Berger T, et al. Midostaurin in combination with intensive chemotherapy is safe and associated with improved remission rates and higher transplantation rates in first remission-a multi-center historical control study. Annals of Hematology 98: 2711-2717, No. 12, Dec 2019. Available from: URL: http://doi.org/10.1007/s00277-019-03795-8

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Cytarabine/daunorubicin/midostaurin. Reactions Weekly 1786, 69 (2020) doi:10.1007/s40278-020-73543-2

    Download citation